Empori Tablet 25 mg (Empagliflozin)
Empagliflozin 25mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.
MFDS item code 202102082 · Approved 2021.03.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to improve blood sugar control in adult patients with type 2 diabetes. It can be administered as monotherapy, and in cases where blood sugar control is challenging, it can be combined with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors. It is particularly important to consider the guidance of a specialist when prescribing it for patients with type 2 diabetes who have cardiovascular disease. This medication helps improve blood sugar control and aids in the treatment of diabetes.
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age and older. Initiation of this medicine is not recommended in patients 85 years of age and older because clinical experience is limited
This medication should not be used by individuals with allergies to its active ingredients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired renal function, end-stage renal disease, or those undergoing dialysis should not use this medication because it may not be effective. Since this medication contains lactose, individuals with genetic issues such as lactose intolerance or galactose intolerance should not take it. Patients with slightly impaired renal function should thoroughly check renal function before administering this medication and adjust the dosage or discontinue it as necessary. Patients with mild to moderate heart failure should use this medication with caution, and it is not recommended for severe heart failure patients. When taken with insulin or insulin secretagogues, there may be a risk of hypoglycemia, so dosage adjustments may be necessary. This medication may cause side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, dehydration, decreased blood pressure, and should be monitored closely for symptoms. Elderly patients or those at risk of fluid loss should be cautious of dehydration and low blood pressure. Serious metabolic abnormalities such as ketoacidosis may occur rarely, so if symptoms like vomiting, abdominal pain, or breathing difficulties appear, seek medical attention immediately. It is advisable not to use this medication during pregnancy, and it is also safe to avoid taking it while breastfeeding. Safety and efficacy have not been established for children under 18 years of age, and it is not used in this population. While no specific toxicity has been reported with overdose, unnecessary use should be avoided, and if an overdose occurs, medical personnel should be informed immediately. Care should be taken to manage any wounds on the feet or surrounding areas, and if there is pain or swelling in the perineal area, consult a doctor immediately. Regularly check renal function, blood pressure, and blood sugar before and after taking this medication, and be cautious of interactions with concurrent medications. Store out of reach of children, and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
Light yellow, double-convex, oval-shaped film-coated tablet
Box - 10 tablets/box [10 tablets/PTP x 1], Box - 30 tablets/box [10 tablets/PTP x 3], Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 25mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.